Phase 1/1b trial of fruquintinib in patients with advanced solid tumors: Preliminary results of the dose expansion cohorts in refractory metastatic colorectal cancer

被引：1
|
作者：
Dasari, Arvind
Hubbard, Joleen M.
Eng, Cathy
Yeckes-Rodin, Heather
Ukrainskyj, Stacey M.
Yang, Zhao
Schelman, William R.
Kania, Marek K.
Bekaii-Saab, Tanios S.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Mayo Clin, Rochester, MN USA
[3] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[4] Cleveland Clin Florida, Port St Lucie, FL USA
[5] HUTCHMED Int, Shanghai, Peoples R China
[6] HUTCHMED Int, Florham Pk, NJ USA
[7] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
93
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors
    Paluri, Ravi
    Madan, Ankit
    Li, Peng
    Jones, Benjamin
    Saleh, Mansoor
    Jerome, Mary
    Miley, Deborah
    Keef, Jennifer
    Robert, Francisco
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 551 - 559
  • [12] First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer
    Winer, Arthur
    Denlinger, Crystal S.
    Vijayvergia, Namrata
    Cohen, Steven J.
    Astaturov, Igor
    Dotan, Efrat
    Gallant, Jean-Nicolas
    Wang, Edward W.
    Kunkel, Miriam
    Lim, Bora
    Harvey, Harold A.
    Sivik, Jeffrey
    Korzekwa, Kenneth
    Ruth, Karen
    White, Kevin
    Cooper, Harry S.
    Ross, Eric A.
    Zhou, Lanlan
    El-Deiry, Wafik S.
    CLINICAL COLORECTAL CANCER, 2021, 20 (01) : E43 - E52
  • [13] A phase 1b, open-label, dose escalation and expansion study of demcizumab plus pembrolizumab in patients with locally advanced or metastatic solid tumors
    Johnson, Melissa
    Rasco, Drew
    Schneider, Brian
    Shu, Catherine
    Jotte, Robert
    Parmer, Hema
    Stagg, Robert
    Lopez, Juanita
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [14] Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors.
    Paluri, Ravi Kumar
    Li, Peng
    Jones, Benjamin Scott
    Madan, Ankit
    Jerome, Mary
    Miley, Debi
    Keef, Jennifer
    Robert, Francisco
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [15] Trial in progress: a multicenter phase 1/1b dose escalation study of WTX-124 as a monotherapy and in combination with pembrolizumab in patients with selected advanced or metastatic solid tumors
    Rodriguez-Rivera, Ildefonso Ismael
    Moser, Justin C.
    Opyrchal, Mateusz
    Curti, Brendan
    Bilen, Mehmet A.
    Park, Saero
    Bruno, Marissa
    Windt, Paul
    Subramanian, Kulandayan K.
    Chopra, Sameer S.
    Isaacs, Randi
    CANCER RESEARCH, 2023, 83 (08)
  • [16] A phase 1b dose-escalation trial of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer (MCRC) patients.
    Delord, JP
    Beale, P
    Van Cutsem, E
    Clarke, S
    Verslype, C
    Bugat, R
    Rakhit, A
    Fettner, S
    Brennscheidt, U
    Feyereislova, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 266S - 266S
  • [17] A PHASE 1/1B DOSE ESCALATION AND COHORT EXPANSION STUDY OF MGC018 IN COMBINATION WITH LORIGERLIMAB IN PATIENTS WITH ADVANCED SOLID TUMORS (AST)
    Powderly, John
    Kaminker, Patrick
    Zhao, Enxu
    Casey, Denise
    Shenderov, Eugene
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A789 - A789
  • [18] A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma
    Chawla, Sant P.
    Goel, Sanjay
    Chow, Warren
    Braiteh, Fadi
    Singh, Arun S.
    Olson, Juneko E. Grilley
    Osada, Atsushi
    Bobe, Iulian
    Riedel, Richard F.
    CLINICAL CANCER RESEARCH, 2020, 26 (16) : 4225 - 4232
  • [19] Avelumab in patients with metastatic urothelial carcinoma: Pooled results from two cohorts of the phase 1b JAVELIN Solid Tumor trial.
    Patel, Manish R.
    Ellerton, John Allan
    Infante, Jeffrey R.
    Agrawal, Manish
    Gordon, Michael S.
    Aljumaliy, Raid
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [20] Phase 1 study of sorafenib and eribulin in patients with advanced, metastatic or refractory solid tumors
    Marme, F.
    Gomez-Roca, C.
    Graudenz, K.
    Huang, F.
    Lettieri, J.
    Pena, C.
    Trnkova, Z.
    Eucker, J.
    ANNALS OF ONCOLOGY, 2016, 27
12345